Electroporative Gene Transfer
Membrane electroporation (MEP) uses short high-voltage pulses to render cell membranes transiently porous and therewith permeable to otherwise impermeable substances. This technique was first described, in vitro , by Neumann in 1982 ( 1 ) . In vivo, this method is restricted to solid tissues accessible to the electrodes used to apply the electric field pulses. Electroporation of cell tissue gains increasing importance especially in clinical applications such as electrochemotherapy (ECT) of, e.g., skin tumors, and for gene therapy ( 2 , 3 , 4 ) . The various applications of MEP include, in addition to the direct functional transfer of genes (electrotransfection, electrogenetransfer) and drugs, the release of proteins, and the electrotransfer of ionic dyes into cells (5 ). But, nevertheless, the mechanism of pore opening and resealing as well as the transfer, especially of DNA, is not yet completely understood.
- Abrogation of the RB-p16Tumor Suppressor Pathway in Human Lung Cancer
- Extraction of Nucleic Acid Templates
- Dissecting the Urokinase Activation Pathway Using Urokinase-Activated Anthrax Toxin
- Cytogenetics of Ovarian Cancer Technical Overview
- What Is Cancer Nanotechnology
- Immune System Functional Pathway Analysis Using Single Cell Network Profiling (SCNP): A Novel Tool in Cancer Immunotherapy
- Manipulating Expression of Endogenous Oncogenic Proteins Using an Antisense Oligonucleotide Approach in Prostate Cancer Cells
- 2-DE-Based Proteomics for the Analysis of Metastasis-Associated Proteins
- Construction of Semisynthetic Antibody Libraries
- Clonality Detection of Expanded T-Cell Populations in Patients With Multiple Myeloma